Terlivaz
NDC 43825-200, Terlipressin, injection, powder, lyophilized, for solution, from Mallinckrodt Hospital Products Inc..
- Product NDC
- 43825-200
- Status
- Listed
- Labeler
- Mallinckrodt Hospital Products Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022231
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43825-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERLIPRESSIN.85 mg/5mL
Pharmacologic classes
Vasopressin Receptor Agonist [EPC]; Vasopressin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43825-200-01 | 43825020001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43825-200-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3a35b86c-f451-4fac-8499-43019e4da354
Use it
Look up 43825-200 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43825-200 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43825-200. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.